Jubilant Ingrevia Share Price

  • 742.3568.61 (10.19%)
  • Volume: 1,39,60,903
  • Closed
  • Last Updated On: 04 Sep, 2024, 03:59 PM IST
Loading...

Jubilant Ingrevia Share...

  • 742.3568.61 (10.19%)
  • Volume: 1,39,60,903
Advertisment

Jubilant Ingrevia share price insights

View All
  • In the last 3 years, only 4.31 % trading sessions saw intraday gains higher than 5 % .

  • Company has spent 1.27% of its operating revenues towards interest expenses and 9.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Daily MACD crossover appeared yesterday. Average price gain of 6.38% within 10 days of this signal in last 10 years.

  • Stock gave a 3 year return of -1.15% as compared to Nifty Midcap 100 which gave a return of 103.8%. (as of last trading session)

  • Jubilant Ingrevia Ltd. share price moved up by 10.19% from its previous close of Rs 673.75. Jubilant Ingrevia Ltd. stock last traded price is 742.35

    Share PriceValue
    Today/Current/Last742.35
    Previous Day673.75673.90

InsightsJubilant Ingrevia

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    67.94
    EPS - TTM
    (₹)
    10.93
    MCap
    (₹ Cr.)
    11,802.73
    Sectoral MCap Rank
    14
    PB Ratio
    (x)
    3.92
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    1.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    726.64
    52W H/L
    (₹)
    749.00 / 406.15

    Jubilant Ingrevia Share Price Returns

    1 Day10.19%
    1 Week13.62%
    1 Month15.96%
    3 Months55.43%
    1 Year45.52%
    3 Years-1.15%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Jubilant Ingrevia belongs to analysts' top-rated companies list?

    View Stock Screeners

    Jubilant Ingrevia Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Jubilant Ingrevia Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 3 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy

    That's all for Jubilant Ingrevia recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy1111
    Buy1111
    Hold1111
    Sell----
    Strong Sell----
    # Analysts3333

    Jubilant Ingrevia Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.27% of its operating revenues towards interest expenses and 9.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income1,033.911,083.94975.181,028.461,083.52
      Total Income Growth (%)-4.6211.15-5.18-5.08-6.11
      Total Expenses953.691,018.92905.07936.19990.67
      Total Expenses Growth (%)-6.4012.58-3.32-5.50-7.65
      EBIT80.2265.0270.1192.2792.85
      EBIT Growth (%)23.38-7.26-24.02-0.6214.33
      Profit after Tax (PAT)48.7429.2538.5657.4957.59
      PAT Growth (%)66.63-24.14-32.93-0.1710.09
      EBIT Margin (%)7.766.007.198.978.57
      Net Profit Margin (%)4.712.703.955.595.32
      Basic EPS (₹)3.081.852.443.643.63
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income978.311,046.51924.811,011.121,040.33
      Total Income Growth (%)-6.5213.16-8.54-2.81-2.72
      Total Expenses917.28977.43876.34915.44948.27
      Total Expenses Growth (%)-6.1511.54-4.27-3.46-5.47
      EBIT61.0369.0848.4795.6892.06
      EBIT Growth (%)-11.6542.52-49.343.9338.90
      Profit after Tax (PAT)32.7730.9819.3357.3254.82
      PAT Growth (%)5.7860.27-66.284.5641.76
      EBIT Margin (%)6.246.605.249.468.85
      Net Profit Margin (%)3.352.962.095.675.27
      Basic EPS (₹)2.061.941.213.603.44
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue4,171.104,806.064,980.85686.73
      Total Revenue Growth (%)-13.21-3.51625.30-
      Total Expenses3,903.514,369.314,271.86596.40
      Total Expenses Growth (%)-10.662.28616.270.04
      Profit after Tax (PAT)182.89307.50476.7154.36
      PAT Growth (%)-40.52-35.50776.97-
      Operating Profit Margin (%)7.749.6014.9514.27
      Net Profit Margin (%)4.426.449.637.94
      Basic EPS (₹)11.5619.3429.9820.78
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue4,022.774,590.604,889.24671.38
      Total Revenue Growth (%)-12.37-6.11628.24-
      Total Expenses3,783.774,223.024,213.77602.90
      Total Expenses Growth (%)-10.400.22598.920.04
      Profit after Tax (PAT)162.45253.41452.2538.59
      PAT Growth (%)-35.90-43.971,072.00-
      Operating Profit Margin (%)7.658.9014.8411.64
      Net Profit Margin (%)4.075.559.305.76
      Basic EPS (₹)10.2015.9128.3914.75

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,731.894,258.883,797.153,378.52
      Total Assets Growth (%)11.1112.1612.390.68
      Total Liabilities1,994.421,592.651,364.031,455.58
      Total Liabilities Growth (%)25.2316.76-6.29-
      Total Equity2,737.472,666.232,433.121,922.94
      Total Equity Growth (%)2.679.5826.53-
      Current Ratio (x)1.381.541.681.59
      Total Debt to Equity (x)0.270.150.090.24
      Contingent Liabilities0.00746.67437.30347.97
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,340.404,058.393,652.133,239.97
      Total Assets Growth (%)6.9511.1212.720.65
      Total Liabilities2,093.341,899.821,669.081,664.12
      Total Liabilities Growth (%)10.1913.820.300.10
      Total Equity2,247.062,158.571,983.051,575.85
      Total Equity Growth (%)4.108.8525.84-
      Current Ratio (x)1.111.261.401.47
      Total Debt to Equity (x)0.370.280.210.41
      Contingent Liabilities0.00487.82487.63342.91

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 568.78 cr for investing activities which is an YoY increase of 20.53%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities429.98462.46452.74112.28
      Net Cash used in Investing Activities-568.78-471.89-71.86-43.66
      Net Cash flow from Financing Activities144.1341.60-417.75-72.37
      Net Cash Flow6.0535.12-35.7373.29
      Closing Cash & Cash Equivalent78.7872.7337.6173.34
      Closing Cash & Cash Equivalent Growth (%)8.3393.38-48.720.01
      Total Debt/ CFO (x)1.700.860.514.06
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities393.64445.64586.80104.18
      Net Cash used in Investing Activities-463.67-475.28-220.76-29.40
      Net Cash flow from Financing Activities64.0732.80-410.23-70.20
      Net Cash Flow-5.963.16-44.1965.64
      Closing Cash & Cash Equivalent18.7024.6621.5065.69
      Closing Cash & Cash Equivalent Growth (%)-24.1714.69-67.270.01
      Total Debt/ CFO (x)2.111.350.726.21

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)6.6811.5319.592.82
      Return on Capital Employed (%)9.2914.8826.963.93
      Return on Assets (%)3.867.2212.551.60
      Interest Coverage Ratio (x)8.6726.9027.9113.33
      Asset Turnover Ratio (x)0.921.161.3820.24
      Price to Earnings (x)39.0618.6215.0276.92
      Price to Book (x)2.612.152.942.16
      EV/EBITDA (x)17.0710.398.4937.57
      EBITDA Margin (%)11.0312.1617.4417.50
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)7.2211.7322.802.44
      Return on Capital Employed (%)10.3414.5528.623.30
      Return on Assets (%)3.746.2412.381.19
      Interest Coverage Ratio (x)6.6113.7418.208.25
      Asset Turnover Ratio (x)0.951.181.4120.64
      Price to Earnings (x)44.4422.6215.85108.70
      Price to Book (x)3.202.653.612.64
      EV/EBITDA (x)18.2611.988.9947.54
      EBITDA Margin (%)10.9911.5217.3214.84

    Financial InsightsJubilant Ingrevia

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent 1.27% of its operating revenues towards interest expenses and 9.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 568.78 cr for investing activities which is an YoY increase of 20.53%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jubilant Ingrevia Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Jubilant Ingrevia

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Jubilant Ingrevia

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Jubilant Ingrevia

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Jubilant Ingrevia Peer Comparison

    • Jubilant Ingrevia Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of -1.15% as compared to Nifty Midcap 100 which gave a return of 103.8%. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of -1.15% as compared to Nifty Midcap 100 which gave a return of 103.8%. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Jubilant Ingrevia67.944.326.689.293.8681.367.744.4211.561.380.271.70
      Gujarat Fluorochem101.825.867.3210.814.7114.8717.0110.1639.601.360.343.19
      Clean Science & Tech63.7713.3020.2826.4817.4715.5041.3630.8322.974.120.000.00
      Galaxy Surfactants33.314.6813.8317.2110.3410.9610.487.9485.032.820.060.25
      Rain Ind.-3.960.73-12.772.00-4.6818.621.84-4.39-27.892.441.112.67
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Rossari Biotech
      • NOCIL Ltd
      • Vidhi Specialty Food
      • Chembond Chem
      • Vikas Ecotech

      Choose from Stocks

      Peers InsightsJubilant Ingrevia

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of -1.15% as compared to Nifty Midcap 100 which gave a return of 103.8%. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Jubilant Ingrevia Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Jubilant Ingrevia Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters51.4751.4751.4751.47
        Pledge2.713.453.453.45
        FII6.556.586.356.30
        DII14.0713.6011.179.18
        Mutual Funds10.5610.239.118.09
        Others27.9028.3531.0133.05
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters8,19,88,22751.47 %0.00
        Pledge22,25,0002.71 %-0.74
        FII1,04,30,2466.55 %-0.02
        DII2,24,15,28914.07 %0.47
        MF1,68,20,26810.56 %0.33
        Others4,44,47,37727.90 %-0.44

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Jubilant Ingrevia Board Meeting/AGM

      • Jubilant Ingrevia Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Jul 16, 2024Jul 09, 2024Board MeetingQuarterly Results
        May 14, 2024May 03, 2024Board MeetingAudited Results & Final Dividend
        Mar 19, 2024Feb 19, 2024POM-
        Jan 30, 2024Jan 23, 2024Board MeetingQuarterly Results & Interim Dividend
        Nov 01, 2023Oct 20, 2023Board MeetingQuarterly Results
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final250%2.5Aug 02, 2024May 14, 2024
        Interim250%2.5Feb 09, 2024Jan 30, 2024
        Final250%2.5Aug 10, 2023May 16, 2023
        Interim250%2.5Feb 10, 2023Jan 31, 2023
        Final250%2.5Aug 23, 2022May 17, 2022
      • No other corporate actions details are available.

      About Jubilant Ingrevia

      Jubilant Ingrevia Ltd., incorporated in the year 2019, is a Small Cap company (having a market cap of Rs 11,824.24 Crore) operating in Chemicals sector. Jubilant Ingrevia Ltd. key Products/Revenue Segments include Other Operating Revenue and Sale of services for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • HS

        Hari S Bhartia

        Co-Chairman & WholeTime Director
        SS

        Shyam S Bhartia

        Chairman
        RK

        Rajesh Kumar Srivastava

        Managing Director & CEO
        CS

        Chandan Singh

        Co-CEO & Whole Time Director
        Show More
      • Walker Chandiok & Co. LLP

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times